Eris Lifesciences' IPO

Eris Lifesciences raised a round of funding on June 16, 2017. Investors include Public.

Eris Lifesciences is a pharmaceutical firm that is engaged in manufacturing, marketing, and selling of branded generics within chronic and acute categories.…

Articles about Eris Lifesciences' IPO: